Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Change in Account Payables (2020 - 2025)

Historic Change in Account Payables for Pulse Biosciences (PLSE) over the last 6 years, with Q3 2025 value amounting to $274000.0.

  • Pulse Biosciences' Change in Account Payables rose 19782.61% to $274000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year increase of 43950.62%. This contributed to the annual value of -$201000.0 for FY2024, which is 17642.59% down from last year.
  • Latest data reveals that Pulse Biosciences reported Change in Account Payables of $274000.0 as of Q3 2025, which was up 19782.61% from $332000.0 recorded in Q2 2025.
  • Pulse Biosciences' 5-year Change in Account Payables high stood at $712000.0 for Q1 2025, and its period low was -$1.5 million during Q2 2022.
  • Over the past 5 years, Pulse Biosciences' median Change in Account Payables value was $92000.0 (recorded in 2024), while the average stood at $65052.6.
  • Its Change in Account Payables has fluctuated over the past 5 years, first skyrocketed by 685555.56% in 2021, then tumbled by 117222.22% in 2023.
  • Over the past 5 years, Pulse Biosciences' Change in Account Payables (Quarter) stood at $185000.0 in 2021, then tumbled by 321.08% to -$409000.0 in 2022, then soared by 206.85% to $437000.0 in 2023, then tumbled by 101.6% to -$7000.0 in 2024, then skyrocketed by 4014.29% to $274000.0 in 2025.
  • Its Change in Account Payables stands at $274000.0 for Q3 2025, versus $332000.0 for Q2 2025 and $712000.0 for Q1 2025.